Change of 3.66% for ACURA PHARMACEUTICALS INC (OTCMKTS:ACUR)’s short interest was noted. It was issued in March by FINRA the 19,800 short interest on ACUR. Previously was reported up change of 3.66% from 19,100 shares. Previous ACUR’s position will need 2 days to restore. It has 8,100 average volume.

Ticker’s shares touched $0.1885 during the last trading session after 21.61% change.Acura Pharmaceuticals, Inc. has volume of 220 shares. Since March 4, 2018 ACUR has 0.00% and is . The stock the S&P 500 by 0.00%.

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products to address medication abuse and misuse.The firm is worth $3.97 million. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products.Currently it has negative earnings. The firm has six additional opioid products in various stages of formulation development.

A couple more Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) news were announced by: Seekingalpha.com which released on October 09, 2018 “Acura Pharma restructures debt with new $1.8M loan – Seeking Alpha”, also Seekingalpha.com on February 07, 2017 announced “Acura Pharmaceuticals Seeks To Raise $5 Million In Offering – Seeking Alpha”, the next Seekingalpha.com is “Egalet: A High Risk/High Reward ~$2.50 Biopharma Stock – Seeking Alpha” on June 15, 2017. Seekingalpha.com has article titled “FDA issues new guidance for opioid use disorders meds – Seeking Alpha”.